Travere Therapeutics, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US89422G1076
USD
35.33
1.34 (3.94%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidated - Balance Sheet Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
0.00
0.00
0.00
0.00
0.00
0.00
Share Warrants & Outstandings
Total Reserve
59.08
200.81
42.85
302.11
211.21
221.20
Shareholder's Funds
59.08
200.81
42.85
302.11
211.21
221.20
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
Long-Term Borrowings
384.39
382.17
379.98
230.49
215.70
207.47
Secured Loans
384.39
382.17
379.98
230.49
215.70
207.47
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax Assets / Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Other Long Term Liabilities
23.99
32.93
112.03
123.85
88.23
83.29
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
Total Non-Current Liabilities
334.30
410.19
487.57
350.43
303.57
288.15
Current Liabilities
Trade Payables
23.53
41.67
17.29
15.14
12.13
26.61
Other Current Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Borrowings
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
Total Current Liabilities
200.75
177.91
142.16
124.09
92.66
95.45
Total Liabilities
594.12
788.91
672.59
776.63
607.44
604.80
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
28.39
32.98
35.24
37.35
39.03
11.73
Less: Accumulated Depreciation
8.76
7.44
5.20
3.05
3.94
1.84
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
19.63
25.54
30.05
34.30
35.09
9.89
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
0.00
0.00
0.00
0.00
0.00
0.00
Intangible assets under development
0.00
0.00
0.00
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Loans & Advances
0.00
0.00
0.00
0.00
0.00
0.00
Other Non Current Assets
53.82
42.16
59.03
11.07
7.81
7.71
Total Non-Current Assets
177.42
172.14
186.15
193.81
197.03
175.74
Current Assets Loans & Advances
Current Investments
312.17
508.68
388.56
387.13
276.82
336.09
Inventories
6.20
9.41
4.52
7.31
7.61
6.08
Sundry Debtors
27.12
21.18
16.65
15.91
15.93
18.05
Cash and Bank
58.53
58.18
61.69
165.75
84.77
62.44
Other Current Assets
406.32
597.44
471.41
576.36
402.26
422.65
Short Term Loans and Advances
2.30
0.00
0.00
0.25
17.14
0.00
Total Current Assets
416.70
616.77
486.44
582.83
410.41
429.06
Net Current Assets (Including Current Investments)
215.95
438.87
344.27
458.74
317.75
333.62
Total Current Assets Excluding Current Investments
416.70
616.77
486.44
582.83
410.41
429.06
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
594.12
788.91
672.59
776.63
607.44
604.80
Contingent Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Total Debt
384.39
382.17
379.98
230.49
215.70
207.47
Book Value per share (adjusted)
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Dec 2024 is -17.75% vs 0.46% in Dec 2023

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Dec 2024 is -27.15% vs -70.61% in Dec 2023

stock-summary

Fixed Assets

YoY Growth in year ended Dec 2024 is -23.14% vs -15.01% in Dec 2023

stock-summary

Investments

No Investments in the last few periods;

stock-summary

Current Assets

YoY Growth in year ended Dec 2024 is -32.44% vs 26.79% in Dec 2023

Compare Balance Sheet Results of Travere Therapeutics, Inc.
Markets Mojo
Figures in Million
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
0
0
0.00
0.00%
Share Warrants & Outstandings
Total Reserve
59.08
671.64
-612.56
-91.20%
Shareholder's Funds
59.08
671.64
-612.56
-91.20%
Minority Interest
0
0
0.00
0.00%
Long-Term Borrowings
384.39
21.10
363.29
1,721.75%
Secured Loans
384.39
21.10
363.29
1,721.75%
Unsecured Loans
0
0
0.00
0.00%
Deferred Tax Assets / Liabilities
0
0
0.00
0.00%
Other Long Term Liabilities
23.99
2.31
21.68
938.53%
Long Term Trade Payables
0
0
0.00
0.00%
Long Term Provisions
0
0
0.00
0.00%
Total Non-Current Liabilities
334.30
22.89
311.41
1,360.46%
Current Liabilities
Trade Payables
23.53
2.14
21.39
999.53%
Other Current Liabilities
0
0
0.00
0.00%
Short Term Borrowings
0
0
0.00
0.00%
Short Term Provisions
0
0
0.00
0.00%
Total Current Liabilities
200.75
47.87
152.88
319.36%
Total Liabilities
594.12
742.40
-148.28
-19.97%
ASSETS
Non-Current Assets
0
0
0.00
0.00%
Gross Block
28.39
4.71
23.68
502.76%
Less: Accumulated Depreciation
8.76
1.27
7.49
589.76%
Less : Impairment of Assets
0
0
0.00
0.00%
Net Block
19.63
3.44
16.19
470.64%
Lease Adjustment
0
0
0.00
0.00%
Capital Work in Progress
0
0
0.00
0.00%
Intangible assets under development
0
0
0.00
0.00%
Pre-operative Expenses pending
0
0
0.00
0.00%
Assets in transit
0
0
0.00
0.00%
Non Current Investments
0
0
0.00
0.00%
Long Term Loans & Advances
0
0
0.00
0.00%
Other Non Current Assets
53.82
0.50
53.32
10,664.00%
Total Non-Current Assets
177.42
3.94
173.48
4,403.05%
Current Assets Loans & Advances
Current Investments
312.17
617.99
-305.82
-49.49%
Inventories
6.20
0
6.20
0.00%
Sundry Debtors
27.12
0
27.12
0.00%
Cash and Bank
58.53
99.59
-41.06
-41.23%
Other Current Assets
406.32
717.58
-311.26
-43.38%
Short Term Loans and Advances
2.30
0
2.30
0.00%
Total Current Assets
416.70
738.46
-321.76
-43.57%
Net Current Assets (Including Current Investments)
215.95
690.59
-474.64
-68.73%
Total Current Assets Excluding Current Investments
416.70
738.46
-321.76
-43.57%
Miscellaneous Expenses not written off
0
0
0.00
0.00%
Total Assets
594.12
742.40
-148.28
-19.97%
Contingent Liabilities
0
0
0.00
0.00%
Total Debt
384.39
21.10
363.29
1,721.75%
Book Value per share (adjusted)
0
0
0.00
0.00%
Annual - Borrowings
Borrowings 310.31 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -17.75% vs 0.46% in Dec 2023

Annual - Other Long Term Liabilities
Other Long Term Liabilities 23.99 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -27.15% vs -70.61% in Dec 2023

Annual - Fixed Assets
Fixed Assets 19.63 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -23.14% vs -15.01% in Dec 2023

Annual - Investments
Markets Mojo
No Investments in the last few periods
stock-summary

No Investments in the last few periods;

Annual - Current Assets
Current Assets 416.70 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -32.44% vs 26.79% in Dec 2023